Literature DB >> 11511894

Prevention of generalized reactions to contrast media: a consensus report and guidelines.

S K Morcos1, H S Thomsen, J A Webb.   

Abstract

The aim of this study was to document, using consensus methodology, current practice for prevention of generalized reactions to contrast media, to identify areas where there is disagreement or confusion and to draw up guidelines for reducing the risk of generalized contrast media reactions based on the survey and a review of the literature. A document with 165 questions was mailed to 202 members of the European Society of Urogenital Radiology. The questions covered risk factors and prophylactic measures for generalized contrast media reactions. Sixty-eight members (34%) responded. The majority indicated that a history of moderate and severe reaction(s) to contrast media and asthma are important risk factors. The survey also indicated that patients with risk factors should receive non-ionic contrast media. In patients at high risk of reaction, if the examination is deemed absolutely necessary, a resuscitation team should be available at the time of the procedure. The majority (91%) used corticosteroid prophylaxis given at least 11 h before contrast medium to patients at increased risk of reaction. The frequency of the dosage varied from one to three times. Fifty-five percent also use antihistamine Hl, mainly administered orally and once. Antihistamine H2 and ephedrine are rarely used. All essential drugs are available on the emergency resuscitation trolley. Patients with risk factors are observed up to 30 min by 48% and up to 60 min by 43% of the responders. Prophylactic measures are not taken before extravascular use of contrast media. Prophylactic drugs are given to patients with a history of moderate or severe generalized reaction to contrast media. In patients with asthma, opinion is divided with only half of the responders giving prophylactic drugs. Aspirin, beta-blockers, interleukin-2 and non-steroid anti-inflammatory drugs are not considered risk factors and therefore are not stopped before injection of contrast media. The survey showed some variability in rating of risk factors for generalized contrast medium reactions, and marked variability in the prophylactic measures used. There remain major areas of uncertainty, and there is insufficient data in the literature to guide practice. Some simple guidelines for prophylaxis of generalized contrast medium reactions are proposed.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511894     DOI: 10.1007/s003300000778

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  20 in total

1.  Management of acute adverse reactions to contrast media.

Authors:  Henrik S Thomsen; Sameh K Morcos
Journal:  Eur Radiol       Date:  2004-01-23       Impact factor: 5.315

2.  [General H1-H2 blockade for anesthetic induction].

Authors:  R Castello
Journal:  Anaesthesist       Date:  2002-05       Impact factor: 1.041

Review 3.  Recent hot topics in contrast media.

Authors:  Henrik S Thomsen
Journal:  Eur Radiol       Date:  2010-12-07       Impact factor: 5.315

Review 4.  A practical guide to diagnose lesser-known immediate and delayed contrast media-induced adverse cutaneous reactions.

Authors:  Ingrid Böhm; Hans H Schild
Journal:  Eur Radiol       Date:  2006-04-20       Impact factor: 5.315

5.  Joint quality improvement guidelines for pediatric arterial access and arteriography: from the Societies of Interventional Radiology and Pediatric Radiology.

Authors:  Manraj K S Heran; Francis Marshalleck; Michael Temple; Clement J Grassi; Bairbre Connolly; Richard B Towbin; Kevin M Baskin; Josee Dubois; Mark J Hogan; Sanjoy Kundu; Donald L Miller; Derek J Roebuck; Steven C Rose; David Sacks; Manrita Sidhu; Michael J Wallace; Darryl A Zuckerman; John F Cardella
Journal:  Pediatr Radiol       Date:  2010-02

Review 6.  Adverse reactions to iodinated contrast media.

Authors:  Wendy Bottinor; Pritam Polkampally; Ion Jovin
Journal:  Int J Angiol       Date:  2013-09

Review 7.  Pharmacological prevention of serious anaphylactic reactions due to iodinated contrast media: systematic review.

Authors:  Martin R Tramèr; Erik von Elm; Pierre Loubeyre; Conrad Hauser
Journal:  BMJ       Date:  2006-07-31

8.  Safety and tolerability of iopromide in patients undergoing cardiac catheterization: real-world multicenter experience with 17,513 patients from the TRUST trial.

Authors:  Ji-Yan Chen; Yong Liu; Ying-Ling Zhou; Ning Tan; Bin Zhang; Ping-Yan Chen; Li-Bing Chen
Journal:  Int J Cardiovasc Imaging       Date:  2015-06-10       Impact factor: 2.357

9.  Safety aspects of iodinated contrast media related to their physicochemical properties: a pharmacoepidemiology study in two Tuscany hospitals.

Authors:  Francesco Lapi; Enrica Cecchi; Claudio Pedone; Francesco Attanasio; Grazia Banchelli; Alfredo Vannacci; Marina Di Pirro; Martina Moschini; Valentina Berni; Rosanna Matucci; Elisabetta Cini; Antonino Scalia; Enrico Tendi; Alessandro Mugelli
Journal:  Eur J Clin Pharmacol       Date:  2008-04-10       Impact factor: 2.953

10.  Shellfish allergy and relation to iodinated contrast media: United Kingdom survey.

Authors:  Mudassar Baig; Ahmad Farag; Jamal Sajid; Rahul Potluri; R Bruce Irwin; Hafiz Mohammed Idrees Khalid
Journal:  World J Cardiol       Date:  2014-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.